# A One Two Gene Therapy Punch to Non-Muscle Invasive Bladder Cancer

Page: https://stenobird.com/podcast/the-bio-report-1092382/a-one-two-gene-therapy-punch-to-non-muscle-invasive-bladder-cancer
Text version: https://stenobird.com/podcast/the-bio-report-1092382/a-one-two-gene-therapy-punch-to-non-muscle-invasive-bladder-cancer.md
Podcast: [The Bio Report](https://stenobird.com/podcast/the-bio-report-1092382)
Published: 2026-02-11T08:00:00+00:00
Episode link: https://thebioreport.podbean.com/e/a-one-two-gene-therapy-punch-to-non-muscle-invasive-bladder-cancer/
Audio file: https://mcdn.podbean.com/mf/web/f4qnvb7jb5evahgu/BR-Ron_Cooper_-_2-11-266c792.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-bio-report-1092382/episodes/a-one-two-gene-therapy-punch-to-non-muscle-invasive-bladder-cancer
Duration seconds: 1432

## Resource

A One‑Two Gene Therapy Punch to Non-Muscle Invasive Bladder Cancer Non–muscle invasive bladder cancer is a common, slow-progressing form of bladder cancer that makes up a majority of the roughly half a million new cases diagnosed each year. For decades, doctors have relied on a weakened bacterium called BCG, an intravesical immunotherapy, as a standard treatment for early-stage disease, but it fails in about 30 to 40 percent of patients. EnGene is taking a different approach with detalimogene, an experimental, non-viral gene therapy designed to trigger a powerful but localized immune response right where the cancer lives in the bladder. We spoke with Ron Cooper, CEO of EnGene, about this therapy for non–muscle invasive bladder cancer, how its dual payload is meant to activate both an innate and adaptive immune response in the bladder, and the company’s $130 million financing at the end of 2025.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-bio-report-1092382/episodes/a-one-two-gene-therapy-punch-to-non-muscle-invasive-bladder-cancer/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-bio-report-1092382/a-one-two-gene-therapy-punch-to-non-muscle-invasive-bladder-cancer.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.